Research Article

The Association of Serum Neurofilament Light Chain and Acute Ischaemic Stroke Is Influenced by Effective Revascularization

Table 1

Patient characteristics.

TotalRevascularizedNonrevascularized value

Demographic data
Age, median (IQR) (y)66.00 (18.25)66.00 (18.00)66.00 (18.00)0.939
Female, (%)46 (40.70)20 (46.50)26 (37.10)0.333

Laboratory values, median (IQR) (pg/mL)
ln(sNfL)3.39 (1.76)3.08 (1.46)3.81 (1.70)0.014

Medical history, (%)
Heart disease44 (38.90)22 (51.20)22 (34.10)0.072
Hypertension66 (58.40)27 (62.80)39 (55.70)0.692
Diabetes33 (29.20)9 (20.90)24 (34.30)0.137
Smoke history34 (30.10)15 (34.90)19 (27.10)0.527
Drink history33 (29.20)18 (41.90)15 (21.40)0.034
Stroke history23 (20.40)10 (23.30)13 (18.60)0.636

Clinical data, median (IQR)
ASPECT scores12.00 (3.00)10.00 (3.00)13.00 (1.75)0.001
NIHSS admission8.00 (10.00)14.00 (10.00)6.00 (6.00)0.005
NIHSS (7D)4.00 (9.00)3.00 (13.00)3.00 (7.00)0.162
Good prognosis, (%)78 (70.90)28 (75.68)50 (64.94)0.165
Arrival time7.00 (20.50)4.00 (4.00)15.00 (18.00)<0.001

sNfL: serum neurofilament light chain; ASPECT: Alberta Stroke Program Early CT; NIHSS: National Institutes of Health Stroke Scale; mRS: modified Rankin Scale. Prognosis (good prognosis, mRS scores 0-2; poor prognosis, mRS scores 3-6).